2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Neoadjuvant Therapy in HR+ BC: Fulvestrant / Fulvestrant + Anastrozole vs. Anastrozole - Was There Significant Improvement of Endocrine-sensitive Disease Rate?

306 views
July 8, 2020
Comments 0
Login to view comments. Click here to Login